190 related articles for article (PubMed ID: 32068452)
1. Pre-clinical models of small cell lung cancer and the validation of therapeutic targets.
Sui JSY; Martin P; Gray SG
Expert Opin Ther Targets; 2020 Mar; 24(3):187-204. PubMed ID: 32068452
[No Abstract] [Full Text] [Related]
2. Current and future therapeutic approaches for the treatment of small cell lung cancer.
Rossi A; Tay R; Chiramel J; Prelaj A; Califano R
Expert Rev Anticancer Ther; 2018 May; 18(5):473-486. PubMed ID: 29544351
[TBL] [Abstract][Full Text] [Related]
3. Prospects of targeted and immune therapies in SCLC.
Hendriks LEL; Menis J; Reck M
Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
[No Abstract] [Full Text] [Related]
4. SCLC-State of the Art and What Does the Future Have in Store?
Kahnert K; Kauffmann-Guerrero D; Huber RM
Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
[TBL] [Abstract][Full Text] [Related]
5. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
[TBL] [Abstract][Full Text] [Related]
6. New insights into small-cell lung cancer development and therapy.
Wang Y; Zou S; Zhao Z; Liu P; Ke C; Xu S
Cell Biol Int; 2020 Aug; 44(8):1564-1576. PubMed ID: 32281704
[TBL] [Abstract][Full Text] [Related]
7. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Semenova EA; Nagel R; Berns A
Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
[TBL] [Abstract][Full Text] [Related]
8. [Research Progress of Immunotherapy and Prognostic Markers in Small Cell Lung Cancer].
Wang Q; Peng W; Jiang M; Wu L
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):182-188. PubMed ID: 32102135
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
Wang H; Wu S; Li Z; Zhang C; Shang X; Zhao C; Li Z; Lin J; Guo J; Wang Z
Cancer Sci; 2023 Feb; 114(2):665-679. PubMed ID: 36178064
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Small Cell Lung Cancer Stem Cells.
Prabavathy D; Ramadoss N
Adv Exp Med Biol; 2019; 1139():41-57. PubMed ID: 31134494
[TBL] [Abstract][Full Text] [Related]
11. Small Cell Lung Cancer.
Kalemkerian GP
Semin Respir Crit Care Med; 2016 Oct; 37(5):783-796. PubMed ID: 27732999
[TBL] [Abstract][Full Text] [Related]
12. Left behind? Drug discovery in extensive-stage small-cell lung cancer.
Riess JW; Lara PN
Clin Lung Cancer; 2014 Mar; 15(2):93-5. PubMed ID: 24529447
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer.
Yu L; Lai Q; Gou L; Feng J; Yang J
J Drug Target; 2021 Jan; 29(1):1-11. PubMed ID: 32700566
[TBL] [Abstract][Full Text] [Related]
14. Breaking the Impasse: Advances in Treatment of Small Cell Lung Cancer.
Saltos A; Antonia S
Clin Chest Med; 2020 Jun; 41(2):269-280. PubMed ID: 32402362
[TBL] [Abstract][Full Text] [Related]
15. Development of targeted therapy and immunotherapy for treatment of small cell lung cancer.
Saito M; Shiraishi K; Goto A; Suzuki H; Kohno T; Kono K
Jpn J Clin Oncol; 2018 Jul; 48(7):603-608. PubMed ID: 29762727
[TBL] [Abstract][Full Text] [Related]
16. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C
Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851
[TBL] [Abstract][Full Text] [Related]
17. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
Demedts IK; Vermaelen KY; van Meerbeeck JP
Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
[TBL] [Abstract][Full Text] [Related]
18. Advances in pharmacotherapy of small cell lung cancer.
Kalemkerian GP
Expert Opin Pharmacother; 2014 Nov; 15(16):2385-96. PubMed ID: 25255939
[TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Reddy HG; Qin A; Kalemkerian GP
Expert Opin Emerg Drugs; 2020 Sep; 25(3):353-366. PubMed ID: 32683991
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the Treatment of Relapsed Small Cell Lung Cancer].
Liu B; Qin J; Zhou J
Zhongguo Fei Ai Za Zhi; 2017 Mar; 20(3):192-198. PubMed ID: 28302222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
